HEADER HYDROLASE/HYDROLASE INHIBITOR 12-SEP-97 1AU8 TITLE HUMAN CATHEPSIN G COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN G; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.21.20 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS INFLAMMATION, SPECIFICITY, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.J.MEDRANO,W.BODE,A.BANBULA,J.POTEMPA REVDAT 4 13-NOV-24 1AU8 1 REMARK LINK REVDAT 3 13-JUL-11 1AU8 1 VERSN REVDAT 2 24-FEB-09 1AU8 1 VERSN REVDAT 1 14-OCT-98 1AU8 0 JRNL AUTH F.J.MEDRANO,W.BODE,A.BANBULA,J.POTEMPA JRNL TITL HUMAN CATHEPSIN G JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 15130 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 15130 REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1786 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 138 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.874 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.87 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.440 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1AU8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171264. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-95 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, ROTAVATA/AGROVATA REMARK 200 DATA SCALING SOFTWARE : CCP4 (AGROVATA, ROTAVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18433 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.11500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.10500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.73000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.10500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.11500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.73000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 65 O HOH A 347 1.76 REMARK 500 CB ARG A 41 O HOH A 314 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 20 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 23 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 48 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 75 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A 86 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 87 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 90 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 97 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 MET A 104 CG - SD - CE ANGL. DEV. = 9.8 DEGREES REMARK 500 ARG A 110 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 111 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 113 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 114 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 116 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG A 125 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 131 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 143 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 MET A 146 CG - SD - CE ANGL. DEV. = 10.0 DEGREES REMARK 500 ARG A 147 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 148 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 156 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 161 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 164 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 178 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 179 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 230 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 36 153.12 65.26 REMARK 500 ALA A 37 86.40 -63.94 REMARK 500 HIS A 71 -61.72 -123.53 REMARK 500 SER A 214 -71.67 -126.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-(3-CARBOXYPROPANOYL)-L-VALYL-N-[(1R)-5-AMINO-1- REMARK 630 PHOSPHONOPENTYL]-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0H8 A 1 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: SIN VAL PRO KPH REMARK 630 DETAILS: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: TAKEN FROM RELEASED PDB ENTRY 1CGH REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: TAKEN FROM RELEASED PDB ENTRY 1CGH REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0H8 A 1 DBREF 1AU8 A 16 244 UNP P08311 CATG_HUMAN 21 244 SEQRES 1 A 224 ILE ILE GLY GLY ARG GLU SER ARG PRO HIS SER ARG PRO SEQRES 2 A 224 TYR MET ALA TYR LEU GLN ILE GLN SER PRO ALA GLY GLN SEQRES 3 A 224 SER ARG CYS GLY GLY PHE LEU VAL ARG GLU ASP PHE VAL SEQRES 4 A 224 LEU THR ALA ALA HIS CYS TRP GLY SER ASN ILE ASN VAL SEQRES 5 A 224 THR LEU GLY ALA HIS ASN ILE GLN ARG ARG GLU ASN THR SEQRES 6 A 224 GLN GLN HIS ILE THR ALA ARG ARG ALA ILE ARG HIS PRO SEQRES 7 A 224 GLN TYR ASN GLN ARG THR ILE GLN ASN ASP ILE MET LEU SEQRES 8 A 224 LEU GLN LEU SER ARG ARG VAL ARG ARG ASN ARG ASN VAL SEQRES 9 A 224 ASN PRO VAL ALA LEU PRO ARG ALA GLN GLU GLY LEU ARG SEQRES 10 A 224 PRO GLY THR LEU CYS THR VAL ALA GLY TRP GLY ARG VAL SEQRES 11 A 224 SER MET ARG ARG GLY THR ASP THR LEU ARG GLU VAL GLN SEQRES 12 A 224 LEU ARG VAL GLN ARG ASP ARG GLN CYS LEU ARG ILE PHE SEQRES 13 A 224 GLY SER TYR ASP PRO ARG ARG GLN ILE CYS VAL GLY ASP SEQRES 14 A 224 ARG ARG GLU ARG LYS ALA ALA PHE LYS GLY ASP SER GLY SEQRES 15 A 224 GLY PRO LEU LEU CYS ASN ASN VAL ALA HIS GLY ILE VAL SEQRES 16 A 224 SER TYR GLY LYS SER SER GLY VAL PRO PRO GLU VAL PHE SEQRES 17 A 224 THR ARG VAL SER SER PHE LEU PRO TRP ILE ARG THR THR SEQRES 18 A 224 MET ARG SER HET 0H8 A 1 31 HETNAM 0H8 N-(3-CARBOXYPROPANOYL)-L-VALYL-N-[(1R)-5-AMINO-1- HETNAM 2 0H8 PHOSPHONOPENTYL]-L-PROLINAMIDE FORMUL 2 0H8 C19 H35 N4 O8 P FORMUL 3 HOH *138(H2 O) HELIX 1 1 ALA A 56 CYS A 58 5 3 HELIX 2 2 ASP A 165 ILE A 171 1 7 HELIX 3 3 VAL A 231 SER A 233 5 3 HELIX 4 4 LEU A 235 ARG A 243 1 9 SHEET 1 A 7 GLN A 81 THR A 84 0 SHEET 2 A 7 ILE A 64 LEU A 68 -1 N LEU A 68 O GLN A 81 SHEET 3 A 7 MET A 30 ILE A 35 -1 N GLN A 34 O ASN A 65 SHEET 4 A 7 ARG A 41 ARG A 48 -1 N GLY A 44 O ALA A 31 SHEET 5 A 7 PHE A 51 THR A 54 -1 N LEU A 53 O PHE A 45 SHEET 6 A 7 MET A 104 LEU A 108 -1 N LEU A 106 O VAL A 52 SHEET 7 A 7 ALA A 85 ARG A 90 -1 N ILE A 89 O LEU A 105 SHEET 1 B 2 LEU A 135 GLY A 140 0 SHEET 2 B 2 ARG A 156 ARG A 161 -1 N LEU A 160 O CYS A 136 SHEET 1 C 4 GLN A 180 VAL A 183 0 SHEET 2 C 4 GLU A 226 ARG A 230 -1 N PHE A 228 O ILE A 181 SHEET 3 C 4 VAL A 204 TYR A 215 -1 N TYR A 215 O VAL A 227 SHEET 4 C 4 PRO A 198 CYS A 201 -1 N CYS A 201 O VAL A 204 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.01 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.02 LINK P 0H8 A 1 OG SER A 195 1555 1555 1.58 CISPEP 1 SER A 36A PRO A 36B 0 0.05 CISPEP 2 PRO A 224 PRO A 225 0 -0.26 SITE 1 AC1 16 HIS A 57 ILE A 99 ARG A 178 ALA A 190 SITE 2 AC1 16 PHE A 191 GLY A 193 ASP A 194 SER A 195 SITE 3 AC1 16 SER A 214 TYR A 215 GLY A 216 LYS A 217 SITE 4 AC1 16 SER A 218 GLU A 226 HOH A 317 HOH A 382 CRYST1 40.230 63.460 80.210 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024857 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015758 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012467 0.00000